10-Q quarterly report · filed Nov 5, 2026

SHOULDER INNOVATIONS, INC. (SI) Q3 2026 10-Q Quarterly Report

Short answer

SHOULDER INNOVATIONS, INC. (SI) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $16M (up 37.7% year over year) with net income of −$7M.

Q3 2026 key financials · XBRL

Revenue
$16M
+37.7% YoY · −5.7% QoQ
Net income
−$7M
+19.3% YoY · +30.6% QoQ
Operating margin
-46.9%
Gross margin
78.5%
EPS (diluted)
−$0.33
−100.1% YoY · +32.7% QoQ

Source: XBRL data from the SHOULDER INNOVATIONS, INC. (SI) Q3 2026 10-Q on SEC EDGAR. USD.

SHOULDER INNOVATIONS, INC. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $16.191M, up 37.7% YoY from $11.756M, driven by higher implant-system sales and customers
  • Gross margin 78.5% vs 76.2% YoY, net loss $7.048M vs $8.729M
  • Implant systems sold 1,976 vs 1,503 YoY, the strongest reported operating metric
  • Nine-month operating cash outflow $26.142M, cash and marketable securities $92.334M at September 30
  • Outlook: funding expected for at least 12 months, with continued losses and increased commercial and R&D spending ahead

Risk Factors

  • No material changes identified from the 2025 Annual Report’s risk factors
  • Equity investment risk: common-stock investors could lose all or part of their investment
  • Business uncertainty risk: unknown or currently immaterial risks could materially harm operations
  • Market risk: adverse developments could reduce the common-stock market price
  • Disclosure risk: investors must assess incorporated annual-report risks alongside quarterly information

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other SHOULDER INNOVATIONS, INC. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.